42.5
Terapia con células madre para la regeneración de tejidos
La terapia con células madre es un método utilizado en medicina regenerativa para reparar y restaurar la función de tejidos y órganos dañados. Las cél…
Las células madre son células no especializadas que pueden autorenovarse o diferenciarse en células específicas de tejido.
Debido a las propiedades únicas de estas células, la terapia con células madre se puede utilizar para regenerar tejidos y órganos dañados o enfermos.
Los pacientes de cáncer con deterioro de la función de la médula ósea, como los diagnosticados con leucemia, linfoma y mieloma, suelen ser candidatos para la terapia con células madre.
La médula ósea, un tejido esponjoso que se encuentra en el centro de los huesos grandes, es la principal fuente de células madre hematopoyéticas o formadoras de sangre. Sin una médula ósea sana, un paciente no puede producir células sanguíneas.
Para comenzar la terapia con células madre, los pacientes con cáncer de sangre primero se exponen a altas dosis de radiación o quimioterapia para destruir las células cancerosas, una terapia de condicionamiento. Esto también puede afectar a sus células madre originales.
Luego, las células madre hematopoyéticas recolectadas del paciente (un trasplante autólogo) o de un donante sano compatible (un trasplante alogénico) se infunden por vía intravenosa en el paciente.
Con el tiempo, las células madre trasplantadas proliferan en la médula ósea y restauran la capacidad del paciente para producir células sanguíneas sanas.
View the full transcript and gain access to JoVE Core videos
Q1: What are stem cells and why are they used in therapy?
Stem cells are unspecialized cells capable of self-renewal and differentiation into tissue-specific cells. Their unique properties make them ideal for regenerative medicine, allowing them to repair and restore function to damaged or diseased tissues and organs. This potential has made stem cell therapy a promising treatment for various conditions, including blood cancers and organ damage.
Q2: How do hematopoietic stem cells help treat blood cancer patients?
Blood cancer patients with impaired bone marrow function receive conditioning therapy—high-dose radiation or chemotherapy—to destroy cancerous cells. Hematopoietic stem cells from the patient or a healthy donor are then infused intravenously. These transplanted cells proliferate in the bone marrow, restoring the patient's ability to produce healthy blood cells and recover bone marrow function.
Q3: What is the difference between autologous and allogeneic stem cell transplants?
Autologous transplants use hematopoietic stem cells harvested from the patient's own bone marrow, while allogeneic transplants use cells from a healthy matching donor. Both approaches aim to restore blood cell production after conditioning therapy. The choice depends on the patient's health condition and availability of matched donors.
Q4: Why are adult stem cells preferred over embryonic stem cells in therapy?
Adult stem cells, such as hematopoietic and mesenchymal stem cells, are more commonly used because embryonic stem cells require embryo sacrifice, raising significant ethical concerns. Although adult stem cells have limited differentiation potential compared to embryonic stem cells, they can still differentiate into various tissue types and are readily available from bone marrow and umbilical cord blood.
Q5: How does the timing of stem cell administration affect tissue repair?
Timing is crucial for repair efficiency when stem cells are administered directly to target tissues. If introduced too early after injury, the inflammatory process impairs stem cell proliferation. However, when administered during the repair phase, stem cells are more readily incorporated into tissue and can proliferate effectively to repair damage.
Q6: What factors determine the success of stem cell therapy strategies?
Stem cell therapy success depends on optimization of multiple factors: the source of stem cells, the target tissue, and the recipient's health condition. Administration route also matters—intravenous delivery works for bone marrow establishment, while direct administration at the target site is more efficient for local tissue repair in organs like the heart, kidney, liver, and muscle.
Q7: What types of tissues can mesenchymal stem cells differentiate into?
Mesenchymal stem cells, found primarily in bone marrow and umbilical cord blood, can differentiate into multiple tissue types including heart, liver, muscle, bone, and some nerve tissues. This broad differentiation potential makes them valuable for regenerative therapy applications targeting various organ systems and tissue types.